Tina Ventura | executive |
William Sibold | executive |
Mardi Dier | executive |
Yasmeen Rahimi | analyst |
Eliana Merle | analyst |
Liisa Bayko | analyst |
Jay Olson | analyst |
Ritu Baral | analyst |
Thomas Smith | analyst |
Akash Tewari | analyst |
Jonathan Wolleben | analyst |
Andrea Tan | analyst |
Good day, thank you for standing by. Welcome to Madrigal's Pharmaceuticals First Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I'd now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. Please go ahead.